TL;DR
This large-scale EHR study of over 1.2 million patients reveals that children and adolescents face a significantly higher risk of cardiovascular complications—including myocarditis, arrhythmias, and heart failure—in the months following a COVID-19 infection. Crucially, these risks persist across all major virus variants and affect both healthy children and those with pre-existing congenital heart defects (CHDs).
What Problem Does This Paper Address?
While the cardiovascular "long-haul" effects of COVID-19 are well-documented in adults, the pediatric landscape has remained blurry. Previous studies were often limited by small sample sizes, short follow-up periods, or a narrow focus on specific conditions like Multisystem Inflammatory Syndrome in Children (MIS-C).
The researchers sought to fill three major gaps:
- Breadth: Assessing a wide spectrum of 18 different cardiovascular outcomes rather than just one or two.
- Duration: Ensuring a minimum six-month follow-up to capture true "post-acute" sequelae.
- Vulnerability: Determining if children with congenital heart defects (CHDs)—the most common congenital disorder in pediatrics—face a disproportionate burden of post-COVID heart issues.
Methods
The authors conducted a retrospective cohort study using electronic health record (EHR) data from the RECOVER (Researching COVID to Enhance Recovery) initiative.
To handle the inherent biases of observational EHR data, they employed several robust statistical techniques:
- Propensity Score Stratification: They adjusted for hundreds of potential confounders (demographics, clinical history, and healthcare utilization) to ensure the COVID-positive and COVID-negative groups were as comparable as possible.
- Poisson Regression: This was used to calculate Relative Risks (RRs) for incident cardiovascular outcomes.
- Negative Control Experiments: To calibrate for residual study bias or unmeasured confounders, they tested the model against 36 outcomes known to be unrelated to COVID-19.
- Exclusion of MIS-C: By excluding patients with MIS-C, the study focused specifically on the direct post-acute cardiovascular impact of the virus itself.
Datasets
The study utilized the RECOVER Database (Version s10), which aggregates data from 19 US children’s hospitals and health institutions.
- Total Cohort: 1,213,322 individuals under age 21.
- COVID-19 Positive: 297,920 patients.
- COVID-19 Negative: 915,402 patients.
- Standardization: Data was mapped to the PCORnet Common Data Model (CDM), allowing for uniform analysis across different hospital systems.
Key Insights and Ideas
- The "Universal" Risk: One of the most striking findings is that the relative risk (RR) for "any cardiovascular outcome" was identical (RR 1.63) for both children with CHDs and those without. This suggests that COVID-19 acts as an independent stressor on the cardiovascular system regardless of baseline health.
- Inflammatory Surge: Children without CHDs saw a nearly three-fold increase in the risk of inflammatory heart diseases like myocarditis and pericarditis (RR 2.92).
- Variant Resilience: The increased cardiovascular risks were not limited to the early, more virulent strains. The researchers found consistent risks across the pre-Delta, Delta, and Omicron periods, suggesting that even "milder" variants can trigger long-term heart issues in youth.
- Symptom vs. Disease: The study captured both clinical diagnoses (like heart failure) and symptoms (like palpitations and chest pain), showing that the post-acute phase involves both structural/functional issues and quality-of-life-impacting symptoms.
Key Results
The study found that 2.32% of COVID-positive children experienced at least one post-acute cardiovascular outcome, compared to 1.38% in the negative group.
Specific Relative Risks (RRs) for the COVID-positive group included:
- Myocarditis: RR 3.82 (for those with CHDs) and RR 3.66 (for those without).
- Heart Failure: RR 1.77 (CHDs) and RR 1.76 (non-CHDs).
- Arrhythmias: RR 1.52 (CHDs) and RR 1.47 (non-CHDs).
- Thromboembolism: RR 1.44 (CHDs) and RR 1.30 (non-CHDs).
- Cardiogenic Shock: A notable RR of 3.15 in the non-CHD group.
Quantitatively, while the absolute risk is higher for kids with CHDs (5.57% vs 4.00%), the relative increase in risk compared to their uninfected peers is significant for everyone.
Limitations and Future Work
The authors acknowledge several limitations common to EHR-based research:
- Misclassification Bias: Reliance on ICD codes without manual chart review can lead to errors, and the rise of at-home testing likely means many COVID-positive cases were missed or mislabeled as negative.
- Healthcare Utilization Bias: Patients who are more "connected" to the healthcare system (visiting more often) are more likely to receive both a COVID diagnosis and a follow-up cardiovascular diagnosis.
- Missing Data: The EHRs lacked family history and genetic data, which are major factors in cardiovascular health.
Future Work: The researchers suggest that future studies should focus on the long-term trajectory of these conditions—specifically whether these post-acute outcomes resolve over years or lead to chronic adult cardiovascular disease. There is also a clear need for clinical trials to determine the best management strategies for pediatric PASC (Post-Acute Sequelae of SARS-CoV-2).
Summary updated